Valuation: Cegedim

Market Cap 14Cr 15Cr 12Cr 11Cr 21Cr 1.43TCr 22Cr 147.98Cr 59Cr 757.84Cr 57Cr 56Cr 2.4TCr P/E 2026 *
6.48x
P/E 2027 * 5.43x
Enterprise Value 34Cr 39Cr 32Cr 29Cr 54Cr 3.65TCr 55Cr 377.13Cr 151.18Cr 1.93TCr 144.93Cr 141.83Cr 6.12TCr EV / Sales 2026 *
0.52x
EV / Sales 2027 * 0.46x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
1 day+1.87%
Current month+1.13%
1 month-9.50%
3 months-6.39%
6 months-14.70%
Current year-27.60%
1 week 9.58
Extreme 9.58
9.95
1 month 9.58
Extreme 9.58
11
Current year 8.5
Extreme 8.5
15.3
1 year 8.5
Extreme 8.5
15.3
3 years 8.5
Extreme 8.5
19.6
5 years 8.5
Extreme 8.5
28.9
10 years 8.5
Extreme 8.5
44.5
Manager TitleAgeSince
Chief Executive Officer 83 25/10/2009
Director of Finance/CFO - 14/06/2016
Corporate Officer/Principal 55 26/11/2015
Director TitleAgeSince
Chairman 83 25/10/2009
Director/Board Member 73 09/08/2010
Director/Board Member 55 26/10/2009
Date Insider Type Main position Quantity % Market Cap. Importance
30/04/26 Buy 751 0.0053%
28/04/26 Buy 74,537 0.5287%
16/04/26 Buy 500 0.0035%
Change 5-day change 1-year change 3-year change Capi.($)
+1.87%0.00%-16.51%-46.10% 15Cr
+6.68%+4.67%+8.06%+57.54% 3,86900Cr
-2.11%-12.76%-9.98%+808.95% 42TCr
-1.95%-14.40%-50.14%+14.51% 38TCr
-0.62%-11.77%+62.24%+185.83% 29TCr
+3.70%+1.47%-5.20%+65.76% 27TCr
-1.50%-9.62%+80.55%+412.11% 25TCr
-0.32%-27.52%-38.70%-10.34% 11TCr
+0.95%-0.51%-25.90%-55.92% 9.58TCr
+1.00%-25.67%+51.83%+156.32% 9.41TCr
Average +0.49%-8.92%+5.62%+158.87% 57.81TCr
Weighted average by Cap. -0.06%+0.03%+7.35%+130.01%

Financials

2026 *2027 *
Net sales 66Cr 74Cr 61Cr 55Cr 103.58Cr 7.01TCr 105.94Cr 724.61Cr 290.48Cr 3.71TCr 278.47Cr 272.51Cr 12TCr 68Cr 77Cr 63Cr 57Cr 107.17Cr 7.25TCr 109.62Cr 749.78Cr 300.57Cr 3.84TCr 288.14Cr 281.98Cr 12TCr
Net income 2.12Cr 2.38Cr 1.94Cr 1.77Cr 3.32Cr 224.84Cr 3.4Cr 23Cr 9.32Cr 119Cr 8.93Cr 8.74Cr 376.97Cr 2.51Cr 2.82Cr 2.3Cr 2.09Cr 3.94Cr 266.55Cr 4.03Cr 28Cr 11Cr 141.08Cr 11Cr 10Cr 446.91Cr
Net Debt 21Cr 23Cr 19Cr 17Cr 33Cr 2.22TCr 34Cr 229.15Cr 92Cr 1.17TCr 88Cr 86Cr 3.72TCr 18Cr 20Cr 17Cr 15Cr 28Cr 1.93TCr 29Cr 199.3Cr 80Cr 1.02TCr 77Cr 75Cr 3.23TCr
Projected Income Statement - Annual - Cegedim
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
6,492
Date Price Change Volume
04/26/04 €9.810 +1.87% 8,956
03/26/03 €9.630 -0.41% 2,909
02/26/02 €9.670 -0.31% 5,898
30/26/30 €9.700 -0.21% 6,861
29/26/29 €9.720 -0.92% 5,261
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Cegedim
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
9.810EUR
Average target price
15.13EUR
Spread / Average Target
+54.26%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Cegedim
  1. Stock Market
  2. Stocks
  3. ALCGM Stock